Recombinant multi-species CCL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is located in a cluster of similar genes in the same region of chromosome 17. These genes encode CC cytokines, which are secreted proteins characterized by two adjacent cysteines. The product of this gene is chemotactic for T cells and monocytes, and acts through C-C chemokine receptor type 1 (CCR1). The proprotein is further processed into numerous smaller functional peptides. Naturally-occurring readthrough transcripts occur from this gene into the downstream gene, CCL14 (chemokine (C-C motif) ligand 14). [provided by RefSeq, Jan 2013]
The Alternative Names of target: CCL15,C-C motif chemokine 15,Chemokine CC-2 (HCC-2), Leukotactin-1 (LKN-1), MIP-1 delta, Macrophage inflammatory protein 5 (MIP-5), Mrp-2b, NCC-3, Small-inducible cytokine A15,LKN1,NCC3,SY15,HCC-2,LKN-1,MIP-5,NCC-3,SCYL3,MIP-1D,MRP-2B,SCYA15,HMRP-2B,MIP-1 delta

Target products collectionGo to CCL15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0069-Ab-1/ GM-Tg-hg-SE0069-Ab-2 Human CCL15 protein Human
GM-Tg-rg-SE0069-Ab-1/ GM-Tg-rg-SE0069-Ab-2 Rat CCL15 protein Rat
GM-Tg-mg-SE0069-Ab-1/ GM-Tg-mg-SE0069-Ab-2 Mouse CCL15 protein Mouse
GM-Tg-cynog-SE0069-Ab-1/ GM-Tg-cynog-SE0069-Ab-2 Cynomolgus/Rhesus macaque CCL15 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0069-Ab-1/ GM-Tg-felg-SE0069-Ab-2 Feline CCL15 protein Feline
GM-Tg-cang-SE0069-Ab-1/ GM-Tg-cang-SE0069-Ab-2 Canine CCL15 protein Canine
GM-Tg-bovg-SE0069-Ab-1/ GM-Tg-bovg-SE0069-Ab-2 Bovine CCL15 protein Bovine
GM-Tg-equg-SE0069-Ab-1/ GM-Tg-equg-SE0069-Ab-2 Equine CCL15 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0069-Ab-1/ GM-Tg-hg-SE0069-Ab-2; GM-Tg-rg-SE0069-Ab-1/ GM-Tg-rg-SE0069-Ab-2;
GM-Tg-mg-SE0069-Ab-1/ GM-Tg-mg-SE0069-Ab-2; GM-Tg-cynog-SE0069-Ab-1/ GM-Tg-cynog-SE0069-Ab-2;
GM-Tg-felg-SE0069-Ab-1/ GM-Tg-felg-SE0069-Ab-2; GM-Tg-cang-SE0069-Ab-1/ GM-Tg-cang-SE0069-Ab-2;
GM-Tg-bovg-SE0069-Ab-1/ GM-Tg-bovg-SE0069-Ab-2; GM-Tg-equg-SE0069-Ab-1/ GM-Tg-equg-SE0069-Ab-2
Products Name CCL15 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL15
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.